Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Enhanced Lipolysis and Fat Oxidation : Preclinical studies have shown that AOD-9604 increases the rate of lipolysis the natural process of triglyceride breakdownwhile simultaneously inhibiting new fat formation in adipose tissue
When your body doesnt produce enough red blood cells, you develop a type of anemic condition known as megaloblastic anemia
Suppliers who answer these clearly and provide documentation up front are a meaningfully different category from listings built around urgency (limited stock, today only) and consumer testimonials a pattern that correlates strongly with underdosed, adulterated, or mislabeled product in independent testing of the peptide market A Note on Grey-Market Peptides and GLP-1 Compounds AOD-9604 is frequently sold by the same vendors offering GLP-1 receptor agonists like semaglutide and tirzepatide under research use only labeling
Composition 5-amino-1MQ Appearance: Lyophilized powder in a sealed research vial Research Focus (non-clinical) Investigation of NNMT inhibition and its downstream metabolic effects Studies on NAD+ metabolism and energy homeostasis in preclinical models Development of analytical methods (HPLC/LC-MS) for small-molecule quantitation Stability and solubility assessment of 5-amino-1MQ under laboratory storage conditions For qualified research professionals and institutional laboratories
